Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients
View ORCID ProfileS. Henriquez, J. Zerbit, T. Bruel, A. Ouedrani, D. Planas, P. Deschamps, I. Staropoli, J. Hadjadj, B. Varet, F. Suarez, N. Ermark, D. Bouscary, L. Willems, G. Fouquet, J. Decroocq, P. Franchi, B. Deau-Fischer, B. Terrier, J. Tamburini, L. Chatenoud, View ORCID ProfileO. Schwartz, M. Vignon
doi: https://doi.org/10.1101/2021.08.08.21261769
S. Henriquez
1Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, APHP.CUP, Hôpital Cochin, 75014, Paris, France
J. Zerbit
2Department of Clinical pharmacy, APHP.CUP, Hôpital Cochin, 75014 Paris, France
T. Bruel
3Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France
4Vaccine Research Institute, Créteil, France
A. Ouedrani
5Department of Biological Immunology, APHP.CUP, Hôpital Necker-Enfants Malades, 75015, Paris, France
6Université de Paris, CNRS UMR 8253 and INSERM UMR1151, Institut Necker-Enfants Malades, Paris, France
D. Planas
3Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France
4Vaccine Research Institute, Créteil, France
P. Deschamps
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
I. Staropoli
3Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France
J. Hadjadj
1Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, APHP.CUP, Hôpital Cochin, 75014, Paris, France
B. Varet
8Department of Adult Hematology, APHP.CUP, Hôpital Necker-Enfants Malades, 75015 Paris, France
F. Suarez
8Department of Adult Hematology, APHP.CUP, Hôpital Necker-Enfants Malades, 75015 Paris, France
9Université de Paris, CNRS ERL8254, INSERM U1163 ⍰ Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Institut Imagine, Paris, France
N. Ermark
10Department of Biological Immunology, APHP.CUP, Hôpital Cochin, 74014 Paris, France
D. Bouscary
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
11Université de Paris, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France
L. Willems
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
G. Fouquet
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
J. Decroocq
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
P. Franchi
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
B. Deau-Fischer
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
B. Terrier
1Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, APHP.CUP, Hôpital Cochin, 75014, Paris, France
12Université de Paris, INSERM, U970, PARCC, Paris, France
J. Tamburini
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
11Université de Paris, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France
13Université de Genève, CMU Rue Michel Servet 1, 1205 Genève
L. Chatenoud
5Department of Biological Immunology, APHP.CUP, Hôpital Necker-Enfants Malades, 75015, Paris, France
6Université de Paris, CNRS UMR 8253 and INSERM UMR1151, Institut Necker-Enfants Malades, Paris, France
O. Schwartz
3Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France
4Vaccine Research Institute, Créteil, France
M. Vignon
7Department of Clinical Hematology, APHP.CUP, Hôpital Cochin, 75014 Paris, France
Article usage
Posted August 09, 2021.
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients
S. Henriquez, J. Zerbit, T. Bruel, A. Ouedrani, D. Planas, P. Deschamps, I. Staropoli, J. Hadjadj, B. Varet, F. Suarez, N. Ermark, D. Bouscary, L. Willems, G. Fouquet, J. Decroocq, P. Franchi, B. Deau-Fischer, B. Terrier, J. Tamburini, L. Chatenoud, O. Schwartz, M. Vignon
medRxiv 2021.08.08.21261769; doi: https://doi.org/10.1101/2021.08.08.21261769
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients
S. Henriquez, J. Zerbit, T. Bruel, A. Ouedrani, D. Planas, P. Deschamps, I. Staropoli, J. Hadjadj, B. Varet, F. Suarez, N. Ermark, D. Bouscary, L. Willems, G. Fouquet, J. Decroocq, P. Franchi, B. Deau-Fischer, B. Terrier, J. Tamburini, L. Chatenoud, O. Schwartz, M. Vignon
medRxiv 2021.08.08.21261769; doi: https://doi.org/10.1101/2021.08.08.21261769
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2666)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12278)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2677)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3920)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (591)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1121)
- Primary Care Research (458)
- Public and Global Health (6556)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)